As of January 2026, the South Korea clinical laboratory services market is identifying as a global leader in high-tech diagnostic integration, with a valuation projected to reach approximately $7 billion this year. The 2026 landscape is defined by the full-scale implementation of the National Integrated Bio Big Data project, which by the second half of 2026 will begin providing phased data...